Rising MRSA blamed on 'production-line' medicine

Production-line medicine is to blame for rising rates of the deadly MRSA superbug infection in the North’s acute hospitals, according to research published today.

Rising MRSA blamed on 'production-line' medicine

Production-line medicine is to blame for rising rates of the deadly MRSA superbug infection in the North’s acute hospitals, according to research published today.

Pressure on managers and doctors to meet targets on the numbers of patients treated was one of the causes.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited